Pseudomyxoma peritonei: two case study and literatures review


  • Ibrahim F. Alsubaiee Department of Surgery, Basrah College of Medicine, Basrah University, Basrah, Iraq



Pseudomyxoma peritonei, Mucinous ascites, Mucocele of appendix


Pseudomyxoma peritonei (PMP) is a rare neoplastic illness with unique clinical and pathologic patterns. This disease characterized by being chronic, indolent, and relapsing. It is diagnostically challenging and very vague disease. It characterized by huge amounts of thick mucinous ascites with multiple omental and peritoneal implants that is gradually fill the abdominal and pelvic cavities. The most common clinical features are progressive abdominal distention with increase in the abdominal girth. Diagnosis of Pseudomyxoma peritonei (PMP) is usually difficult due to its vague symptoms especially in the early stages. Ultrasound examination is very useful and generally has pictures similar to that of CT scan images. Treatment of Pseudomyxoma peritonei (PMP) is cytoreductive (debulking) surgery to remove the mucin and the tumor implants in the peritoneal cavity. This is followed by intraoperative hyperthermic peritoneal chemotherapy (HIPEC). Recurrence of pseudomyxoma peritonei (PMP) patients is quite common as particularly when the disease is diagnosed and treated in the late stage.


Hinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg. 1998;85:1332-9.

Bradley RF, Stewart JH, Russell GB, Levine EA, Geisinger KR. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformely treated at a single institution, with literatures review. Am J Surg Pathol. 2006;30:551-9.

Mukherjee A, Cecil TD, Moran BJ. Pseudomyxoma peritonei usually originates from the appendix: a review of evidence. Eur J Gynaecol Oncol. 2004;25:411-4.

Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003:585-603.

Galani E, Marx GMF, Steer CB, Culora G, Harper PG. Pseudomyxoma peritonei: the controversial disease. Int J Gynaecol Cancer. 2003;13:413-8.

Sherer DM, Abulafia O, Eliakim R. Pseudomyxoma peritonei: a review of current literature. Gynecol Obstet Invest. 2001;51(2):73-80.

Ronnett BM, Shmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynaecol Pathol. 1997;16:1-9.

Ronnett BM, Zahn CM, Kurman RG, Kass mf, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol. 1995;19(12):1390-408.

Esquivel FL, Sugarbaker PH. Clinical presentation of pseudomyxoma peritonei syndrome. Br J Surg. 2000;(10)1414-1418.

Ruths V, Acherman YI, van de Vijver MI, Hart AA, Verwall VJ,Zoetmulder FA. Pseudomyxoma peritonii: a review of 62 cases. Eur J Surg Oncol 2003;29: 682-8.

Loungnarath R, Causeret S, Bossoard N, Faheez M, Sayag-Beaujard AC, Brignad C, Gilly F, Glehen O. Cytoreductive surgery with intraperitoneal chemohyperthermia for treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum. 2005;48:1372-9.

Deraco M, Gronchi A, Mazzaferro V, Inglese MG, Pennacchoili E, Kusamura S, Rizzi M, Anselmi RA, Jr, Vaglini M. Feasibilty of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei. Tumori. 2002;88:370-5.

Dhage-Ivatury S, Sugarbaker PH. Update on the surgical treatment of mucocele of the appendix. J Am Coll Surg. 2006;202:680-4.

Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome. Ann Surg Oncol. 2007;14:439-99.

Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin N Am. 2003;12:703-27.






Case Reports